BioNTech Unveils $150M mRNA Vaccine Facility in Rwanda, Pledges to Democratize Vaccine Tech in Africa 🧬 🇷🇼
BioNTech has officially launched its $150 million mRNA vaccine manufacturing facility in Kigali, Rwanda. The state-of-the-art BioNTainers, designed for global application and adaptability to regional needs, symbolize a revolutionary approach to pharmaceutical production. The facility is expected to be fully operational by 2025, employing at least 100 staff members. BioNTech plans to conduct clinical trials for malaria, tuberculosis, and HIV vaccines in Africa by 2024, reaffirming its commitment to democratizing vaccine technology on the continent. The inauguration event witnessed the presence of African leaders and international organizations, signaling a significant step towards healthcare resilience in the region. 🌍💉
#BioNTech #VaccineInnovation #HealthcareForAll
Read more on BenjaminDada
